SHALLCROSS STEVEN A 4
4 · Theriva Biologics, Inc. · Filed Jan 23, 2023
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Purchase
Common Stock
2023-01-20$0.75/sh+25,000$18,705→ 135,000 total
4 · Theriva Biologics, Inc. · Filed Jan 23, 2023
Common Stock